Terms: = Testicular cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
15 results:
1. Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness.
Kardoust Parizi M; Margulis V; Bagrodia A; Bekku K; Klemm J; Matsukawa A; Alimohammadi A; Motlagh RS; Mostafaei H; Laukhtina E; Shariat SF
Urol Oncol; 2024 Apr; 42(4):102-109. PubMed ID: 38360519
[TBL] [Abstract] [Full Text] [Related]
2. Strong apoptotic response of testis tumor cells following cisplatin treatment.
Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
[TBL] [Abstract] [Full Text] [Related]
3. Extrinsic apoptosis and senescence involved in growth kinetics of seminoma to cisplatin.
Yin Y; Peng J; Zheng X; Zhou J; Wang Y; Dai Y; Yin G; Tang Y
Clin Exp Pharmacol Physiol; 2023 Feb; 50(2):140-148. PubMed ID: 36222180
[TBL] [Abstract] [Full Text] [Related]
4. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract] [Full Text] [Related]
5. Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.
Rocco NR; Stroup SP; Abdul-Muhsin HM; Marshall MT; Santomauro MG; Christman MS; L'Esperance JO; Castle EP
World J Urol; 2020 Apr; 38(4):859-867. PubMed ID: 31502033
[TBL] [Abstract] [Full Text] [Related]
6. Cisplatin resistance in germ cell tumours: models and mechanisms.
Jacobsen C; Honecker F
Andrology; 2015 Jan; 3(1):111-21. PubMed ID: 25546083
[TBL] [Abstract] [Full Text] [Related]
7. Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the fas/fasL pathway.
Koster R; Timmer-Bosscha H; Bischoff R; Gietema JA; de Jong S
Cell Death Dis; 2011 Apr; 2(4):e148. PubMed ID: 21509038
[TBL] [Abstract] [Full Text] [Related]
8. Sequential X-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro.
Eisenmann S; Voigt W; Müller T; Dempke W
Anticancer Res; 2010 Nov; 30(11):4471-6. PubMed ID: 21115895
[TBL] [Abstract] [Full Text] [Related]
9. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.
Glendenning JL; Barbachano Y; Norman AR; Dearnaley DP; Horwich A; Huddart RA
Cancer; 2010 May; 116(10):2322-31. PubMed ID: 20225230
[TBL] [Abstract] [Full Text] [Related]
10. Male germ cell development: turning on the apoptotic pathways.
Tripathi R; Mishra DP; Shaha C
J Reprod Immunol; 2009 Dec; 83(1-2):31-5. PubMed ID: 19889463
[TBL] [Abstract] [Full Text] [Related]
11. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital.
Cvancarova M; Samuelsen SO; Magelssen H; Fosså SD
J Clin Oncol; 2009 Jan; 27(3):334-43. PubMed ID: 19075285
[TBL] [Abstract] [Full Text] [Related]
12. Mechanisms of toxic damage to spermatogenesis.
Boekelheide K
J Natl Cancer Inst Monogr; 2005; (34):6-8. PubMed ID: 15784812
[TBL] [Abstract] [Full Text] [Related]
13. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to fas-mediated apoptosis.
Spierings DC; de Vries EG; Stel AJ; te Rietstap N; Vellenga E; de Jong S
Oncogene; 2004 Jun; 23(28):4862-72. PubMed ID: 15122333
[TBL] [Abstract] [Full Text] [Related]
14. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
Spierings DC; de Vries EG; Vellenga E; de Jong S
J Pathol; 2003 Jun; 200(2):137-48. PubMed ID: 12754734
[TBL] [Abstract] [Full Text] [Related]
15. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract] [Full Text] [Related]